$CBDY
Target Group Inc. Stock $cbdy

$cbdy Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000141057823000922 Filed on May 08, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$759.0K	$0.00
YoY Change
Cost Of Revenue	$369.3K
YoY Change
Gross Profit	$389.7K
YoY Change
Gross Profit Margin	51.35%
Selling, General & Admin	$255.0K	$136.3K
YoY Change	-3.01%	-55.07%
% of Gross Profit	65.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$229.6K	$212.7K
YoY Change	1.88%	-6.56%
% of Gross Profit	58.91%
Operating Expenses	$500.4K	$340.7K
YoY Change	74.68%	-2.15%
Operating Profit	-$110.7K
YoY Change
Interest Expense	$369.1K	$353.6K
YoY Change	35.51%	22.49%
% of Operating Profit
Other Income/Expense, Net	$1.075M	-$405.0K
YoY Change	101.19%	91.48%
Pretax Income	$963.8K	-$745.7K
YoY Change	289.26%	33.23%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	$963.8K	-$745.7K
YoY Change	289.26%	33.23%
Net Earnings / Revenue	126.99%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	617.0M	617.0M
Diluted Shares Outstanding	727.4M	617.0M

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.048M	$49.34K
YoY Change	817.46%	-74.66%
Cash & Equivalents	$1.057M	$57.83K
Short-Term Investments
Other Short-Term Assets	$51.36K	$685.2K
YoY Change	-89.67%	93.48%
Inventory	$1.815M	$0.00
Prepaid Expenses	$42.67K	$41.75K
Receivables	$2.068K	$2.068K
Other Receivables	$4.810K	$18.78K
Total Short-Term Assets	$2.921M	$755.4K
YoY Change	288.65%	15.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.773M	$5.346M
YoY Change	-8.13%	-20.34%
Goodwill	$269.2K	$263.3K
YoY Change	-92.57%	-92.95%
Intangibles
YoY Change
Long-Term Investments	$1.024M	$1.270M
YoY Change	53.8%	-39.04%
Other Assets
YoY Change
Total Long-Term Assets	$6.098M	$6.938M
YoY Change	-42.73%	-44.99%
TOTAL ASSETS
Total Short-Term Assets	$2.921M	$755.4K
Total Long-Term Assets	$6.098M	$6.938M
Total Assets	$9.019M	$7.694M
YoY Change	-20.88%	-42.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$507.0K	$7.582M
YoY Change	-81.13%	320.48%
Accrued Expenses	$2.434M	$112.9K
YoY Change	96.87%	-95.13%
Deferred Revenue
YoY Change
Short-Term Debt	$990.00	$990.00
YoY Change	-98.81%	0.0%
Long-Term Debt Due	$1.540M	$1.632M
YoY Change	-23.24%	41.35%
Total Short-Term Liabilities	$8.020M	$7.708M
YoY Change	81.59%	50.11%
LONG-TERM LIABILITIES
Long-Term Debt	$6.332M	$6.069M
YoY Change	4.12%	-17.18%
Other Long-Term Liabilities	$1.290M	$1.292M
YoY Change	-10.82%	-15.13%
Total Long-Term Liabilities	$7.565M	$7.293M
YoY Change	-20.06%	-32.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.020M	$7.708M
Total Long-Term Liabilities	$7.565M	$7.293M
Total Liabilities	$15.59M	$15.00M
YoY Change	12.29%	-6.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.57M	-$31.53M
YoY Change	15.01%	17.54%
Common Stock	$61.70K	$61.70K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.567M	-$7.307M
YoY Change
Total Liabilities & Shareholders Equity	$9.019M	$7.694M
YoY Change	-20.88%	-42.01%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$963.8K	-$745.7K
YoY Change	289.26%	33.23%
Depreciation, Depletion And Amortization	$229.6K	$212.7K
YoY Change	1.88%	-6.56%
Cash From Operating Activities	-$122.1K	-$186.8K
YoY Change	-90.94%	-226.15%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$984.4K	-$538.9K
YoY Change	-25.89%	290.51%
Cash From Investing Activities	$984.4K	-$538.9K
YoY Change	-25.89%	289.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	113.3K	554.6K
YoY Change	-299.61%	703.93%
NET CHANGE
Cash From Operating Activities	-122.1K	-186.8K
Cash From Investing Activities	984.4K	-538.9K
Cash From Financing Activities	113.3K	554.6K
Net Change In Cash	975.6K	-171.1K
YoY Change	-1388.77%	-317.44%
FREE CASH FLOW
Cash From Operating Activities	-$122.1K	-$186.8K
Capital Expenditures		$0.00
Free Cash Flow		-$186.8K
YoY Change		-225.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5554225
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0012
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0009
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	617025999
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	617025999
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001586554
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Trading Symbol TradingSymbol	CBDY
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	617025999
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	617025999
CY2023Q1	cbdy	Allowance On Value Added Tax Recoverable AllowanceOnValueAddedTaxRecoverable	0
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-55066
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	TARGET GROUP INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3621499
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20 Hempstead Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Hamilton
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L8W 2E7
CY2023Q1	dei	City Area Code CityAreaCode	1 905
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	541-3833
CY2023Q1	dei	Security12g Title Security12gTitle	Common Stock, Par Value $0.0001
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	617025999
CY2023Q1	us-gaap	Cash Cash	49335
CY2022Q4	us-gaap	Cash Cash	223843
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	8498
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	8490
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2068
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2068
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	41748
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	41714
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	15088
CY2023Q1	us-gaap	Due From Joint Ventures Current DueFromJointVenturesCurrent	634965
CY2022Q4	us-gaap	Due From Joint Ventures Current DueFromJointVenturesCurrent	630180
CY2023Q1	us-gaap	Other Receivables OtherReceivables	3695
CY2022Q4	us-gaap	Other Receivables OtherReceivables	3692
CY2023Q1	us-gaap	Assets Current AssetsCurrent	755397
CY2022Q4	us-gaap	Assets Current AssetsCurrent	909987
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5346196
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1270336
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	775577
CY2023Q1	us-gaap	Goodwill Goodwill	263331
CY2022Q4	us-gaap	Goodwill Goodwill	263117
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58453
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	62728
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	6938316
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6655647
CY2023Q1	us-gaap	Assets Assets	7693713
CY2022Q4	us-gaap	Assets Assets	7565634
CY2023Q1	us-gaap	Bank Overdrafts BankOverdrafts	506
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	506
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2613317
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2296935
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	35254
CY2023Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	4968182
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	4468535
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112943
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110586
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	480
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	480
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	12454
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	15125
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7707882
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6927421
CY2023Q1	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	6001509
CY2022Q4	us-gaap	Accounts Payable Related Parties Noncurrent AccountsPayableRelatedPartiesNoncurrent	5877930
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1291467
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1319619
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	345
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	489
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7293321
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7198038
CY2023Q1	us-gaap	Liabilities Liabilities	15001203
CY2022Q4	us-gaap	Liabilities Liabilities	14125459
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	100
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	100
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	61703
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	61703
CY2023Q1	cbdy	Shares To Be Issued Total SharesToBeIssuedTotal	175245
CY2022Q4	cbdy	Shares To Be Issued Total SharesToBeIssuedTotal	175182
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24985697
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24985697
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31529387
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30783678
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000848
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-998829
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7307490
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6559825
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7693713
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7565634
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	223
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	11239
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	78324
CY2022Q1	us-gaap	Management Fee Expense ManagementFeeExpense	27885
CY2022Q1	cbdy	Salary And Wage Nonofficer SalaryAndWageNonofficer	-17831
CY2023Q1	us-gaap	Legal Fees LegalFees	57940
CY2022Q1	us-gaap	Legal Fees LegalFees	66944
CY2023Q1	us-gaap	Depreciation Depreciation	212686
CY2022Q1	us-gaap	Depreciation Depreciation	227624
CY2023Q1	cbdy	Operating Lease Income Expense OperatingLeaseIncomeExpense	11090
CY2022Q1	cbdy	Operating Lease Income Expense OperatingLeaseIncomeExpense	23527
CY2023Q1	cbdy	General And Administrative Income Expense GeneralAndAdministrativeIncomeExpense	-2629
CY2022Q1	cbdy	General And Administrative Income Expense GeneralAndAdministrativeIncomeExpense	-20197
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	340712
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	348193
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2975
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	17646
CY2023Q1	us-gaap	Interest Expense InterestExpense	353606
CY2022Q1	us-gaap	Interest Expense InterestExpense	288688
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2275
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-34034
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4275
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	60185
CY2022Q1	cbdy	Allowance Recovery For Sales Tax Recoverable AllowanceRecoveryForSalesTaxRecoverable	509
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-43963
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	46125
CY2023Q1	cbdy	Debt Issuance Costs DebtIssuanceCosts	12403
CY2022Q1	cbdy	Debt Issuance Costs DebtIssuanceCosts	13249
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-404997
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-211506
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-745709
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-559699
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-745709
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-559699
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2019
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	9875
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-747728
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-549824
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0012
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0009
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	617025999
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	617025999
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6559825
CY2023Q1	cbdy	Shares To Be Issued As Compensation To Intellectual Property Rights Value SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue	63
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-745709
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2019
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7307490
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2152112
CY2022Q1	cbdy	Shares To Be Issued As Compensation To Intellectual Property Rights Value SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue	153
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-559699
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	9875
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-2701783
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-745709
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-559699
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2975
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	17646
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	223
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	583
CY2022Q1	cbdy	Allowance For Sales Tax Recoverable AllowanceForSalesTaxRecoverable	509
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	212686
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	227624
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	60053
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	67802
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-43963
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	46125
CY2023Q1	cbdy	Debt Issuance Costs DebtIssuanceCosts	12403
CY2022Q1	cbdy	Debt Issuance Costs DebtIssuanceCosts	13249
CY2023Q1	cbdy	Increase Decrease In Sales Tax Recoverable IncreaseDecreaseInSalesTaxRecoverable	-50405
CY2022Q1	cbdy	Increase Decrease In Sales Tax Recoverable IncreaseDecreaseInSalesTaxRecoverable	63773
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	362991
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	483587
CY2023Q1	cbdy	Change In Operating Lease Liability Net ChangeInOperatingLeaseLiabilityNet	79990
CY2022Q1	cbdy	Change In Operating Lease Liability Net ChangeInOperatingLeaseLiabilityNet	84596
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-186760
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	148043
CY2022Q1	cbdy	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	322
CY2023Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	538911
CY2022Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	138002
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538911
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-138324
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	554550
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	78980
CY2022Q1	cbdy	Settlement Payable SettlementPayable	138002
CY2023Q1	cbdy	Settlement Payable SettlementPayable	138002
CY2022Q1	cbdy	Payment For Settlement Payable PaymentForSettlementPayable	10000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	554550
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68980
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-171121
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	78699
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3379
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2824
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232333
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122151
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57833
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203674
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	280
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	153
CY2023Q1	us-gaap	Area Of Land AreaOfLand	44000
CY2020	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2023Q1	cbdy	Warrants Purchase WarrantsPurchase	7211213
CY2023Q1	cbdy	Settlement Liabilities Current And Noncurrent SettlementLiabilitiesCurrentAndNoncurrent	0
CY2021	cbdy	Settlement Liabilities Current And Noncurrent SettlementLiabilitiesCurrentAndNoncurrent	10000
CY2023Q1	cbdy	Working Capital Deficit WorkingCapitalDeficit	6996419
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31529387
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.</span></p>
CY2022Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0
CY2022	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0
CY2023Q1	cbdy	Revenue From Investments In Joint Venture RevenueFromInvestmentsInJointVenture	200641
CY2022Q1	cbdy	Revenue From Investments In Joint Venture RevenueFromInvestmentsInJointVenture	1096321
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	7701206
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1631801
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6069405
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	99000
CY2023Q1	cbdy	Impairment Of Inventory ImpairmentOfInventory	99000
CY2022	cbdy	Impairment Of Inventory ImpairmentOfInventory	99000
CY2017Q3	us-gaap	Area Of Land AreaOfLand	44000
CY2019Q2	us-gaap	Area Of Land AreaOfLand	44000
CY2023Q1	cbdy	Depreciation Expense Recorded DepreciationExpenseRecorded	287468
CY2022Q1	cbdy	Depreciation Expense Recorded DepreciationExpenseRecorded	227042
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8233970
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2887774
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5346196
CY2020Q2	cbdy	Loans To Joint Venture Term Of Debt LoansToJointVentureTermOfDebt	P5Y
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1143730
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3305121
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3252355
CY2023Q1	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	11863655
CY2023Q1	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	8766054
CY2022Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	10913576
CY2022Q4	cbdy	Assets Balance Of Joint Venture AssetsBalanceOfJointVenture	8057493
CY2023Q1	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	12250071
CY2023Q1	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	9051578
CY2022Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	11181077
CY2022Q4	cbdy	Liabilities Balance Of Joint Venture LiabilitiesBalanceOfJointVenture	8254989
CY2023Q1	cbdy	Equity Of Joint Venture EquityOfJointVenture	-386417
CY2023Q1	cbdy	Equity Of Joint Venture EquityOfJointVenture	-285523
CY2022Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-267501
CY2022Q4	cbdy	Equity Of Joint Venture EquityOfJointVenture	-197496
CY2021	cbdy	Class Of Warrant Or Right Warrants Exercised During Period ClassOfWarrantOrRightWarrantsExercisedDuringPeriod	0
CY2018Q2	cbdy	Business Acquisition Equity Interest Issuable Percentage BusinessAcquisitionEquityInterestIssuablePercentage	0.4627
CY2020Q3	cbdy	Debt Issuance Costs DebtIssuanceCosts	251518
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	117475
CY2023Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	49579
CY2023Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	67896
CY2023Q1	cbdy	Accrued Interest Converted Into Principal AccruedInterestConvertedIntoPrincipal	554175
CY2023Q1	cbdy	Accrued Interest Converted Into Principal AccruedInterestConvertedIntoPrincipal	750000
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	3636380
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2686921
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	3636380
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	2686921
CY2023Q1	us-gaap	Line Of Credit Facility Periodic Payment Interest LineOfCreditFacilityPeriodicPaymentInterest	234779
CY2023Q1	us-gaap	Line Of Credit Facility Periodic Payment Interest LineOfCreditFacilityPeriodicPaymentInterest	317741
CY2023Q1	cbdy	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	671359
CY2023Q1	cbdy	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	908593
CY2023Q1	cbdy	Number Of Operating Lease Facilities NumberOfOperatingLeaseFacilities	2
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.16
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	244319
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	322939
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	326168
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	329430
CY2023Q1	cbdy	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	1122457
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2345313
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	940903
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1404410
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112943
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1291467
CY2021	cbdy	Gross Operating Lease Expense GrossOperatingLeaseExpense	67802
CY2023Q1	cbdy	Gross Operating Leases Rent And Utilities Expenses GrossOperatingLeasesRentAndUtilitiesExpenses	-11090
CY2021	cbdy	Gross Operating Leases Rent And Utilities Expenses GrossOperatingLeasesRentAndUtilitiesExpenses	122805
CY2021	cbdy	Recoverable Expenses From Jv Co Related To Rent And Utilities RecoverableExpensesFromJvCoRelatedToRentAndUtilities	214134
CY2023Q1	cbdy	Operating Lease Expenses Total OperatingLeaseExpensesTotal	-11090
CY2021	cbdy	Operating Lease Expenses Total OperatingLeaseExpensesTotal	-23527
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	10
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	8
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	15125
CY2023Q1	cbdy	Effect Of Conversion Of Convertible Notes EffectOfConversionOfConvertibleNotes	0
CY2023Q1	cbdy	Derivative Liability Changes Due To Issuance DerivativeLiabilityChangesDueToIssuance	0
CY2023Q1	cbdy	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-2671
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	12454
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	617025999
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	617025999
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	100
CY2022Q1	cbdy	Schedule Of Shares To Be Issued ScheduleOfSharesToBeIssued	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 14 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 203,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,620</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,594,648</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,245</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;"></span></p>
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	115000
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	73000
CY2023Q1	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.05
CY2023Q1	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q1	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	160
CY2022Q4	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q3	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q2	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q1	cbdy	Share Based Compensation Share Based Payments Forfeiture Rate ShareBasedCompensationShareBasedPaymentsForfeitureRate	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.300
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.79
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.79
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.99
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.06
CY2022Q4	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2022Q3	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2022Q2	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2022Q1	cbdy	Fair Value Assumptions Term FairValueAssumptionsTerm	P2Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q4	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	176
CY2022Q3	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	288
CY2022Q2	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	306
CY2022Q1	cbdy	Business Acquisition Fair Value Of Equity Interest Issued Or Issuable BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable	430
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15766675
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	53950001
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	489
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	160
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-304
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	345
CY2023Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1376427
CY2023Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1862805
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	10720

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001410578-23-000922-index-headers.html	Edgar Link	pending
0001410578-23-000922-index.html	Edgar Link	pending
0001410578-23-000922.txt	Edgar Link	pending
0001410578-23-000922-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20230331.xsd	Edgar Link	pending
tmb-20230331x10q.htm	Edgar Link	pending
tmb-20230331xex10d32.htm	Edgar Link	pending
tmb-20230331xex10d33.htm	Edgar Link	pending
tmb-20230331xex31d1.htm	Edgar Link	pending
tmb-20230331xex31d2.htm	Edgar Link	pending
tmb-20230331xex32d1.htm	Edgar Link	pending
tmb-20230331_def.xml	Edgar Link	unprocessable
tmb-20230331_cal.xml	Edgar Link	unprocessable
tmb-20230331_lab.xml	Edgar Link	unprocessable
tmb-20230331_pre.xml	Edgar Link	unprocessable
tmb-20230331x10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBDY
Target Group Inc. Stock $cbdy

2023 Q2 Form 10-Q Financial Statement

#000141057823000922 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDY Target Group Inc. Stock $cbdy

2023 Q2 Form 10-Q Financial Statement

#000141057823000922 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDY
Target Group Inc. Stock $cbdy